Ippoliti Lorenzo, Pizzo Andrea, Paolino Agostino, Coppeta Luca, Bizzarro Giuseppe, Ferrari Cristiana, Mazza Andrea, Salvi Claudia, Buonomo Ersilia, Cenko Fabian, Magrini Andrea, Pietroiusti Antonio
Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Vaccines (Basel). 2025 Jul 21;13(7):771. doi: 10.3390/vaccines13070771.
Despite the widespread implementation of childhood vaccination programmes, hepatitis B virus (HBV) infection remains an ongoing occupational risk for healthcare students. In multi-ethnic and international university settings, differences in vaccination programmes and immune responses must be considered. This retrospective study aimed to assess the prevalence of protective levels of anti-HBs among medical students at an international university in Rome, exploring associations with demographic and vaccination-related factors.
Data were collected from routine occupational health surveillance conducted in 2023. Anti-HB titres were measured in 507 students, and information on age, sex, country of birth, age at vaccination, and time since the last dose was analysed.
Overall, 55.0% of students had antibody levels of at least 10 mIU/mL, indicating serological protection. Higher seroprotection rates were observed among students vaccinated in the first year of life compared to those vaccinated later. A significant decline in antibody titres was also associated with longer intervals since vaccination. Students born outside Europe tended to show lower levels of protection.
These results emphasise the importance of screening future healthcare professionals and continuously monitoring antibody titres to help reduce HBV infections.
尽管儿童疫苗接种计划已广泛实施,但乙型肝炎病毒(HBV)感染仍是医学生持续面临的职业风险。在多民族和国际化的大学环境中,必须考虑疫苗接种计划和免疫反应的差异。这项回顾性研究旨在评估罗马一所国际大学医学生中抗-HBs保护水平的流行情况,探讨其与人口统计学和疫苗接种相关因素的关联。
数据收集自2023年进行的常规职业健康监测。对507名学生测量了抗-HB滴度,并分析了年龄、性别、出生国家、接种疫苗时的年龄以及距最后一剂疫苗接种后的时间等信息。
总体而言,55.0%的学生抗体水平至少为10 mIU/mL,表明具有血清学保护作用。与较晚接种疫苗的学生相比,在出生后第一年接种疫苗的学生血清保护率更高。抗体滴度的显著下降也与接种疫苗后的间隔时间延长有关。出生在欧洲以外的学生往往显示出较低的保护水平。
这些结果强调了筛查未来医疗保健专业人员以及持续监测抗体滴度以帮助减少HBV感染的重要性。